Deals & Capital Markets
BioMarin Bets $4.8 Billion on Amicus to Create Rare Disease Powerhouse
Dec 19, 2025
You're signed outSign in or to get full access.
Leadership at BIOMARIN PHARMACEUTICAL
Browse executives, board members, and key leadership.
Executives at BIOMARIN PHARMACEUTICAL
Alexander Hardy
President and Chief Executive Officer
CEO
Executive
Board
Brian R. Mueller
Executive Vice President and Chief Financial Officer
Executive
C. Greg Guyer
Executive Vice President and Chief Technical Officer
Executive
Cristin Hubbard
Executive Vice President and Chief Commercial Officer
Executive
G. Eric Davis
Executive Vice President, Chief Legal Officer and Secretary
Executive
Gregory R. Friberg
Executive Vice President and Chief Research & Development Officer
Executive